Frazier Life Sciences Ix, L.p. - Net Worth and Insider Trading
Frazier Life Sciences Ix, L.p. Net Worth
The estimated net worth of Frazier Life Sciences Ix, L.p. is at least $222 Million dollars as of 2024-04-28. Frazier Life Sciences Ix, L.p. is the 10% Owner of Mirum Pharmaceuticals Inc and owns about 3,566,912 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $87 Million. Frazier Life Sciences Ix, L.p. is the 10% Owner of Phathom Pharmaceuticals Inc and owns about 7,284,269 shares of Phathom Pharmaceuticals Inc (PHAT) stock worth over $67 Million. Frazier Life Sciences Ix, L.p. is also the 10% Owner of Tarsus Pharmaceuticals Inc and owns about 1,917,157 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $61 Million. Besides these, Frazier Life Sciences Ix, L.p. also holds Passage Bio Inc (PASG) . Details can be seen in Frazier Life Sciences Ix, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frazier Life Sciences Ix, L.p. has not made any transactions after 2020-10-20 and currently still holds the listed stock(s).
Transaction Summary of Frazier Life Sciences Ix, L.p.
Frazier Life Sciences Ix, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frazier Life Sciences Ix, L.p. owns 4 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , Phathom Pharmaceuticals Inc (PHAT) , and Passage Bio Inc (PASG) among others .
Click here to see the complete history of Frazier Life Sciences Ix, L.p.’s form 4 insider trades.
Insider Ownership Summary of Frazier Life Sciences Ix, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2020-10-20 | 10 percent owner |
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-29 | 10 percent owner |
| PASG | Passage Bio Inc | 2020-03-03 | 10 percent owner |
| MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 10 percent owner |
Frazier Life Sciences Ix, L.p. Latest Holdings Summary
Frazier Life Sciences Ix, L.p. currently owns a total of 4 stocks. Among these stocks, Frazier Life Sciences Ix, L.p. owns 3,566,912 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $87 Million and a weighting of 39.27%. Frazier Life Sciences Ix, L.p. owns 7,284,269 shares of Phathom Pharmaceuticals Inc (PHAT) as of October 29, 2019, with a value of $67 Million and a weighting of 30.1%. Frazier Life Sciences Ix, L.p. also owns 1,917,157 shares of Tarsus Pharmaceuticals Inc (TARS) as of October 20, 2020, with a value of $61 Million and a weighting of 27.65%. The other 1 stocks Passage Bio Inc (PASG) have a combined weighting of 2.98% among all his current holdings.
Latest Holdings of Frazier Life Sciences Ix, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 3,566,912 | 24.46 | 87,246,668 |
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-29 | 7,284,269 | 9.18 | 66,869,589 |
| TARS | Tarsus Pharmaceuticals Inc | 2020-10-20 | 1,917,157 | 32.04 | 61,425,710 |
| PASG | Passage Bio Inc | 2020-03-03 | 5,009,219 | 1.32 | 6,612,169 |
Holding Weightings of Frazier Life Sciences Ix, L.p.
Frazier Life Sciences Ix, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Frazier Life Sciences Ix, L.p. has made a total of 1 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost Frazier Life Sciences Ix, L.p. around $7 Million.
According to the SEC Form 4 filings, Frazier Life Sciences Ix, L.p. has made a total of 1 transactions in Phathom Pharmaceuticals Inc (PHAT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Phathom Pharmaceuticals Inc is the acquisition of 1,052,631 shares on October 29, 2019, which cost Frazier Life Sciences Ix, L.p. around $20 Million.
According to the SEC Form 4 filings, Frazier Life Sciences Ix, L.p. has made a total of 1 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the acquisition of 312,500 shares on October 20, 2020, which cost Frazier Life Sciences Ix, L.p. around $5 Million.
More details on Frazier Life Sciences Ix, L.p.'s insider transactions can be found in the Insider Trading History of Frazier Life Sciences Ix, L.p. table.Insider Trading History of Frazier Life Sciences Ix, L.p.
- 1
Frazier Life Sciences Ix, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Frazier Life Sciences Ix, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frazier Life Sciences Ix, L.p. is 33.29%. GuruFocus also compares Frazier Life Sciences Ix, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Frazier Life Sciences Ix, L.p. within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frazier Life Sciences Ix, L.p.'s insider trading performs compared to the benchmark.
Performance of Frazier Life Sciences Ix, L.p.
Average Return
36.86%
Outperforming Transactions
75%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.69 | 33.29 | 27.17 | 36.86 | -16.95 | -19.59 |
| Relative Return to S&P 500(%) | 1.43 | 27.29 | 16.37 | 17.45 | -33.89 | -28.61 |
Frazier Life Sciences Ix, L.p. Ownership Network
Ownership Network List of Frazier Life Sciences Ix, L.p.
Ownership Network Relation of Frazier Life Sciences Ix, L.p.
Frazier Life Sciences Ix, L.p. Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Frazier Life Sciences Ix, L.p. is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include Chief Human Resources Officer Dianne C. Whitfield , General Counsel Bryan Wahl , and Chief Commercial Officer Aziz Mottiwala .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Frazier Life Sciences Ix, L.p. made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 346,867 shares made by Bobak R. Azamian , a net sale of 31,966 shares made by Leonard M. Greenstein , and a net sale of 20,877 shares made by Aziz Mottiwala .
In summary, during the past 3 months, insiders sold 28,810 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 28,810 shares. During the past 18 months, 450,842 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 440,336 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Frazier Life Sciences Ix, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Frazier Life Sciences Ix, L.p.. You might contact Frazier Life Sciences Ix, L.p. via mailing address: 601 Union Street, Suite 3200, Seattle Wa 98101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
